ClinicalTrials.Veeva

Menu

High Protein Intake in Critically Ill Ventilated Patients

Cairo University (CU) logo

Cairo University (CU)

Status

Completed

Conditions

Intensive Care Unit Syndrome

Treatments

Dietary Supplement: Whey protein

Study type

Observational

Funder types

Other

Identifiers

NCT04977440
MS 29-2020

Details and patient eligibility

About

This prospective interventional randomized control study was conducted on forty patients with respiratory failure; all patients were intubated and mechanically ventilated for at least three days. Twenty patients received high protein intake using whey protein, with daily follow-up of the blood sugar level, serum electrolytes, and chemistry. ICU outcome regarding food intolerance, 30-day mortality, length of MV and ICU-stay was recorded

Enrollment

40 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age >18 years
  • Mechanically ventilated patients (for three days or more )

Exclusion criteria

  • Age < 18 years old
  • Contraindication for enteral nutrition (gut ischemia, obstruction, or perforation)
  • Expected intolerance for enteral nutrition (paralytic ileus)
  • Inability to start enteral nutrition within 24-hours(i.e. surgery or other interventions)
  • Short bowel syndrome
  • Hemodynamic instability ( i.e shock state, need for vasopressors )
  • Child C liver cirrhosis or acute liver failure
  • Dialysis dependency

Trial design

40 participants in 2 patient groups

standard protein
high protein
Treatment:
Dietary Supplement: Whey protein

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems